CREDIT SUISSE FIRST BOSTON 13D/13G Filings for Evelo Biosciences, Inc. (EVLO)

CREDIT SUISSE FIRST BOSTON 13D and 13G filings for Evelo Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-02
1:43 pm
Purchase		 2022-12-31 13G Evelo Biosciences, Inc.
EVLO		 CREDIT SUISSE FIRST BOSTON 183,919
3.350%		 5,595increase
(+3.14%)		 Filing
2022-02-14
1:25 pm
Purchase		 2021-12-31 13G Evelo Biosciences, Inc.
EVLO		 CREDIT SUISSE FIRST BOSTON 178,324
6.670%		 43,049increase
(+31.82%)		 Filing
2021-02-12
4:16 pm
Purchase		 2020-12-31 13G Evelo Biosciences, Inc.
EVLO		 CREDIT SUISSE FIRST BOSTON 135,276
5.860%		 135,276increase
(New Position)		 Filing